0001493152-21-004072.txt : 20210216 0001493152-21-004072.hdr.sgml : 20210216 20210216190439 ACCESSION NUMBER: 0001493152-21-004072 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210104 FILED AS OF DATE: 20210216 DATE AS OF CHANGE: 20210216 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sakiris Spiro Kevin CENTRAL INDEX KEY: 0001830957 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39825 FILM NUMBER: 21641847 MAIL ADDRESS: STREET 1: 708 THIRD AVENUE, 6TH FLOOR CITY: NEW YORK CITY STATE: NY ZIP: 10017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GBS Inc. CENTRAL INDEX KEY: 0001725430 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 821512711 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 733 THIRD AVENUE STREET 2: FLOOR 15 CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 646-790-5756 MAIL ADDRESS: STREET 1: 733 THIRD AVENUE STREET 2: FLOOR 15 CITY: NEW YORK STATE: NY ZIP: 10017 FORMER COMPANY: FORMER CONFORMED NAME: Glucose Biosensor Systems (Greater China) Holdings, Inc. DATE OF NAME CHANGE: 20171214 4 1 ownership.xml X0306 4 2021-01-04 0 0001725430 GBS Inc. GBS 0001830957 Sakiris Spiro Kevin C/O GBS, INC., 708 THIRD AVENUE, 6TH FLOOR, NEW YORK NY 10017 0 1 0 0 Chief Financial Officer Common Stock 2021-01-04 4 X 0 1479 A 6258 D Series B Warrants 2021-01-04 4 X 0 1479 D Common Stock 1479 0 D Represents exercise of the Series B Common Stock Purchase Warrant (the "Warrant") to purchase 1,479 shares of the Company's common stock. The Reporting Person paid the exercise price of $17.00 per share on a cashless basis. The Warrant was exercisable until the fifth anniversary of the issuance date. /s/ Spiro Sakiris 2021-02-16